These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8703911

  • 21. Dihydrotestosterone (DHT) modulates the ability of NSAIDs to induce apoptosis of prostate cancer cells.
    Andrews P, Krygier S, Djakiew D.
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):179-86. PubMed ID: 11935209
    [Abstract] [Full Text] [Related]

  • 22. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret JP, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Léger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Thérien M, Wang Z, Webb JK, Wong E, Chan CC.
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [Abstract] [Full Text] [Related]

  • 23. Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells.
    Ferrera P, Arias C.
    Neurochem Int; 2005 Dec; 47(8):589-96. PubMed ID: 16169124
    [Abstract] [Full Text] [Related]

  • 24. Nonsteroidal antiinflammatory drugs inhibit cyclooxygenase-2 enzyme activity but not mRNA expression in human macrophages.
    Barrios-Rodiles M, Keller K, Belley A, Chadee K.
    Biochem Biophys Res Commun; 1996 Aug 23; 225(3):896-900. PubMed ID: 8780708
    [Abstract] [Full Text] [Related]

  • 25. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
    Greig GM, Francis DA, Falgueyret JP, Ouellet M, Percival MD, Roy P, Bayly C, Mancini JA, O'Neill GP.
    Mol Pharmacol; 1997 Nov 23; 52(5):829-38. PubMed ID: 9351974
    [Abstract] [Full Text] [Related]

  • 26. Arachidonic acid and nonsteroidal anti-inflammatory drugs induce conformational changes in the human prostaglandin endoperoxide H2 synthase-2 (cyclooxygenase-2).
    Smith T, McCracken J, Shin YK, DeWitt D.
    J Biol Chem; 2000 Dec 22; 275(51):40407-15. PubMed ID: 11006278
    [Abstract] [Full Text] [Related]

  • 27. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
    Song Y, Connor DT, Doubleday R, Sorenson RJ, Sercel AD, Unangst PC, Roth BD, Gilbertsen RB, Chan K, Schrier DJ, Guglietta A, Bornemeier DA, Dyer RD.
    J Med Chem; 1999 Apr 08; 42(7):1151-60. PubMed ID: 10197959
    [Abstract] [Full Text] [Related]

  • 28. Altered sensitivity of aspirin-acetylated prostaglandin G/H synthase-2 to inhibition by nonsteroidal anti-inflammatory drugs.
    Mancini JA, Vickers PJ, O'Neill GP, Boily C, Falgueyret JP, Riendeau D.
    Mol Pharmacol; 1997 Jan 08; 51(1):52-60. PubMed ID: 9016346
    [Abstract] [Full Text] [Related]

  • 29. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases.
    Panara MR, Greco A, Santini G, Sciulli MG, Rotondo MT, Padovano R, di Giamberardino M, Cipollone F, Cuccurullo F, Patrono C.
    Br J Pharmacol; 1995 Nov 08; 116(5):2429-34. PubMed ID: 8581280
    [Abstract] [Full Text] [Related]

  • 30. Prostaglandin H synthase: perturbation of the tyrosyl radical as a probe of anticyclooxygenase agents.
    Kulmacz RJ, Palmer G, Tsai AL.
    Mol Pharmacol; 1991 Nov 08; 40(5):833-7. PubMed ID: 1658613
    [Abstract] [Full Text] [Related]

  • 31. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
    Schmassmann A, Peskar BM, Stettler C, Netzer P, Stroff T, Flogerzi B, Halter F.
    Br J Pharmacol; 1998 Mar 08; 123(5):795-804. PubMed ID: 9535006
    [Abstract] [Full Text] [Related]

  • 32. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2.
    Smith WL, Meade EA, DeWitt DL.
    Ann N Y Acad Sci; 1994 Apr 18; 714():136-42. PubMed ID: 8017762
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D, Charleson S, Cromlish W, Mancini JA, Wong E, Guay J.
    Can J Physiol Pharmacol; 1997 Sep 18; 75(9):1088-95. PubMed ID: 9365818
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Inhibitor-induced changes in the intrinsic fluorescence of human cyclooxygenase-2.
    Houtzager V, Ouellet M, Falgueyret JP, Passmore LA, Bayly C, Percival MD.
    Biochemistry; 1996 Aug 20; 35(33):10974-84. PubMed ID: 8718891
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs.
    DeWitt DL, Meade EA, Smith WL.
    Am J Med; 1993 Aug 09; 95(2A):40S-44S. PubMed ID: 8357002
    [Abstract] [Full Text] [Related]

  • 40. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
    Velázquez C, Praveen Rao PN, Knaus EE.
    J Med Chem; 2005 Jun 16; 48(12):4061-7. PubMed ID: 15943479
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.